BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16523366)

  • 1. A further validation of subareolar injection technique for breast sentinel lymph node biopsy.
    D'Eredita G; Giardina C; Guerrieri AM; Berardi T
    Ann Surg Oncol; 2006 May; 13(5):701-7. PubMed ID: 16523366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subareolar injection may be more accurate than other techniques for sentinel lymph node biopsy in breast cancer.
    D'Eredita' G; Ferrarese F; Cecere V; Massa ST; de Carne F; Fabiano G
    Ann Surg Oncol; 2003 Oct; 10(8):942-7. PubMed ID: 14527915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Subareolar injection for sentinel lymph node biopsy in multiple breast cancer].
    D'Eredità G; Troilo VL; Giardina C; Ingravallo G; Rubini G; Lattanzio V; Berardi T
    G Chir; 2006; 27(11-12):436-41. PubMed ID: 17198554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
    Kern KA
    J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E; Sedlmayer F
    World J Surg; 2003 Dec; 27(12):1291-4. PubMed ID: 14574485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.
    Pelosi E; Ala A; Bellò M; Douroukas A; Migliaretti G; Berardengo E; Varetto T; Bussone R; Bisi G
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):937-42. PubMed ID: 15838690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer.
    D'Eredita' G; Giardina C; Ingravallo G; Rubini G; Lattanzio V; Berardi T
    Breast; 2007 Jun; 16(3):316-22. PubMed ID: 17293114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
    Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy.
    Layeeque R; Kepple J; Henry-Tillman RS; Adkins L; Kass R; Colvert M; Gibson R; Mancino A; Korourian S; Klimberg VS
    Ann Surg; 2004 Jun; 239(6):841-5; discussion 845-8. PubMed ID: 15166963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.
    Kern KA
    J Am Coll Surg; 1999 Dec; 189(6):539-45. PubMed ID: 10589589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience.
    Mudun A; Sanli Y; Ozmen V; Turkmen C; Ozel S; Eroglu A; Igci A; Yavuz E; Tuzlali S; Muslumanoglu M; Cantez S
    Clin Nucl Med; 2008 Apr; 33(4):262-7. PubMed ID: 18356664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid.
    Kern KA; Rosenberg RJ
    J Am Coll Surg; 2000 Nov; 191(5):479-89. PubMed ID: 11085727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic mapping in early stage breast cancer: comparison between periareolar and subdermal injection.
    Pelosi E; Baiocco C; Ala A; Gay E; Bello M; Varetto T; Giani R; Bussone R; Bisi G
    Nucl Med Commun; 2003 May; 24(5):519-23. PubMed ID: 12717068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
    Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
    Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
    Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
    J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.
    Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D
    Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of subareolar blue dye and peritumoral RI for sentinel lymph node biopsy.
    Tsunoda N; Iwata H; Sarumaru S; Mizutani M; Iwase T; Miura S
    Breast Cancer; 2002; 9(4):323-8. PubMed ID: 12459714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients.
    Motomura K; Komoike Y; Hasegawa Y; Kasugai T; Inaji H; Noguchi S; Koyama H
    J Surg Oncol; 2003 Feb; 82(2):91-6; discussion 96-7. PubMed ID: 12561063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.